BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zizzo G, Tamburello A, Castelnovo L, Laria A, Mumoli N, Faggioli PM, Stefani I, Mazzone A. Immunotherapy of COVID-19: Inside and Beyond IL-6 Signalling. Front Immunol 2022;13:795315. [PMID: 35340805 DOI: 10.3389/fimmu.2022.795315] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Jing H, Wu X, Xiang M, Liu L, Novakovic VA, Shi J. Pathophysiological mechanisms of thrombosis in acute and long COVID-19. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.992384] [Reference Citation Analysis]
2 Kalpachidou T, Riehl L, Schöpf CL, Ucar B, Kress M. Proinflammatory cytokines and their receptors as druggable targets to alleviate pathological pain. PAIN 2022;163:S79-S98. [DOI: 10.1097/j.pain.0000000000002737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Falcinelli E, Petito E, Gresele P. The role of platelets, neutrophils and endothelium in COVID-19 infection. Expert Rev Hematol 2022. [PMID: 35930267 DOI: 10.1080/17474086.2022.2110061] [Reference Citation Analysis]
4 Zha D, Fu M, Qian Y. Vascular Endothelial Glycocalyx Damage and Potential Targeted Therapy in COVID-19. Cells 2022;11:1972. [PMID: 35741101 DOI: 10.3390/cells11121972] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Kudryavtsev I, Rubinstein A, Golovkin A, Kalinina O, Vasilyev K, Rudenko L, Isakova-sivak I. Dysregulated Immune Responses in SARS-CoV-2-Infected Patients: A Comprehensive Overview. Viruses 2022;14:1082. [DOI: 10.3390/v14051082] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
6 Marino A, Munafò A, Augello E, Bellanca CM, Bonomo C, Ceccarelli M, Musso N, Cantarella G, Cacopardo B, Bernardini R. Sarilumab Administration in COVID-19 Patients: Literature Review and Considerations. Infectious Disease Reports 2022;14:360-71. [DOI: 10.3390/idr14030040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
7 Marino A, Campanella E, Ceccarelli M, Larocca L, Bonomo C, Micali C, Munafò A, Celesia B, Nunnari G, Cacopardo B. Sarilumab administration in patients with severe COVID‑19: A report of four cases and a literature review. World Acad Sci J 2022;4:24. [DOI: 10.3892/wasj.2022.159] [Reference Citation Analysis]